glp-1 singapore A doctor ranks the myths he hears every week 🩺 Do you agree with his #1? 👇, Dr Zac, our Medical Director, ranks the myths patients bring into the consult room — from the With GLP-1 medications on the

Racial disparities in obesity-related cardiovascular mortality in the United States: Temporal Trends From 1999 to 2020

GLP-1 agonists like semaglutide are introduced at a very low dose (to minimize side effects) and gradually increased over weeks

[97] observed a potential association between semaglutide and NAION, with incidence rates of 4.28 and 7.64 per 1,000 person-years in patients with T2DM and those who were overweight or obese, respectively, over 36 months

These days, it is increasingly common for patients to mention that they are taking a medication for weight loss or blood sugar management

Although the findings in the CANVAS trial showed a higher risk of amputation when taking canafliglozin compared to placebo [92], no significant difference in the risk of this complication was observed in the CREDENCE study [88]